Royal Australian and New Zealand College of Psychiatrists. Clinical practice guidelines for the treatment of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry2005; 39: 1–30–
2.
National Institute for Healthcare and Clinical Excellence (NICE): Guidance on the use of newer (atypical) antipsychotic drugs for the treatment of schizophrenia. Technology Appraisal no. 43, 2002. Available from URL: http://www.nice.org.uk–
3.
LiebermanJ. Comparative effectiveness of antipsychotic drugs: a commentary on the Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study and Clinical Antipsychotic Trials of Intervention Effectiveness. Archives of General Psychiatry2006; 63: 1069–1072–
4.
JonesPBBarnesTDaviesL. Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS). Archives of General Psychiatry2006; 63: 1079–1087–
5.
TanCShinfukuNSimK. Psychotropic prescription practices in East Asia: looking back and peering ahead. Current Opinion in Psychiatry2008; 21: 645–650–
6.
SernyakMRosenheckR. Antipsychotic use in the treatment of outpatients with schizophrenia in the VA from fiscal years 1999 to 2006. Psychiatric Services2008; 59: 567–569–
7.
Alessi-SeveriniSBiscontriRCollinsDKozyrskyjASareenJEnnsM. Utilisation and costs of antipsychotic agents: A Canadian population-based study, 1996 – 2006. Psychatric Services2008; 59: 547–553–
8.
SahaSChantDWelhamJMcGrathJ. A systematic review of the prevalence of schizophrenia. PLoS Med2005May; 2(5): e141–
9.
EssaliAAl-Haj HaasanNLiCRathboneJ. Clozapine versus typical neuroleptic medication for schizophrenia. Cochrane Database of Systematic Reviews 2009–
BreierABuchananRWKirkpatrickB. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. American Journal of Psychiatry1994; 151: 20–26–
